Prenetics Global Ltd. is a genomics-driven health sciences company, which engages in the early detection, prevention, and treatment of cancer. It operates through the Prevention and Diagnostics segments. The firm offers products and services under the brands of CircleDNA, Insighta, and ACT Genomics. Its prevention arm, CircleDNA, uses whole exome sequencing to offer comprehensive consumer DNA test. The Insighta, a joint venture with scientist Prof. Dennis Lo, develops multi-cancer early detection technologies. Lastly, ACT Genomics treatment unit, an Asia-based company that achieved FDA clearance for comprehensive genomic profiling of solid tumors via ACTOnco. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and is headquartered in Hong Kong.
No Data